Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/67605
Title: | The in-house monoclonal antibody against γ-globin chain; Thal N/B, accurately measured F cells in SEA-α thalassemia 1 trait |
Authors: | Lamplaimas Tangpan Tippawadee Jansai Sasiwan Kerdpoo Tiemjan Kiewkarnkha Ekthong Limweeraprajak Thanusak Tatu |
Authors: | Lamplaimas Tangpan Tippawadee Jansai Sasiwan Kerdpoo Tiemjan Kiewkarnkha Ekthong Limweeraprajak Thanusak Tatu |
Keywords: | Biochemistry, Genetics and Molecular Biology;Health Professions;Immunology and Microbiology;Medicine |
Issue Date: | 2-Nov-2019 |
Abstract: | © 2019, © 2019 Taylor & Francis. The monoclonal antibody (mAb) against γ-globin chain clone Thal N/B was produced. It was aimed at measuring the quantity of HbF (α2γ2)-containing red blood cells or F cells by flow cytometry. However, it may cross-react with Hb Bart’s (γ4) which is present in the SEA-α thalassemia 1 trait. We measured FC levels by flow cytometry using this in-house mAb for 100 blood samples. Prevalence of high FC trait in this cohort was 51%. Ten of 12 SEA-α thalassemia 1 trait were included in the 51% high FC individuals. Comparing FC levels in the 51 high FC individuals having and not having the SEA-α thalassemia 1 trait showed no difference of FC levels. It was concluded that Hb Bart’s did not interfere with FC measurement by flow cytometry using the in-house Thal N/B mAb. Therefore, it can be used for measuring F cell levels in regions having a high prevalence of the SEA-α thalassemia 1 trait. The findings of this research should apply to other clones of anti-γ-globin chain mAb that are aimed for HbF/FC quantification. |
URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073934815&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67605 |
ISSN: | 15324230 15321819 |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.